Test-of-cure stool cultures for traveler's diarrhea. 1988

C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
Program in Infectious Diseases and Clinical Microbiology, University of Texas Medical School, Houston 77030.

Whether enteropathogens were eradicated or persisted in test-of-cure stool cultures from 251 patients with traveler's diarrhea, the durations of diarrhea were similar within the antimicrobial agent-treated (32 versus 33 h) and placebo-treated (82 versus 96 h) groups. Routine test-of-cure stool cultures can be useful for evaluating treatment failures and for assessing asymptomatic carriage of enteropathogens after treatment, but they are not mandated in the design of placebo-controlled antimicrobial treatment trials in traveler's diarrhea when the focus of the trial is clinical efficacy.

UI MeSH Term Description Entries
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014195 Travel MOVEMENT across different GEOGRAPHIC LOCATIONS. Land Travel,Sea Travel,Land Travels,Sea Travels,Travel, Land,Travel, Sea,Travels,Travels, Land,Travels, Sea

Related Publications

C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
July 2008, The Medical letter on drugs and therapeutics,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
July 1982, Schweizerische medizinische Wochenschrift,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
October 2021, Deutsche medizinische Wochenschrift (1946),
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
July 1982, The Western journal of medicine,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
September 2012, Infectious disease clinics of North America,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
July 2019, Canadian family physician Medecin de famille canadien,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
September 1993, Gastroenterology clinics of North America,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
July 1999, Medizinische Monatsschrift fur Pharmazeuten,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
May 1973, Ugeskrift for laeger,
C D Ericsson, and H L DuPont, and J J Mathewson, and P C Johnson, and F J de la Cabada, and J A Bitsura
June 2004, Journal of gastroenterology and hepatology,
Copied contents to your clipboard!